[Principles to follow with drugs--optically active compounds].
Czarnecki
A
A
Instytut Leków, Warszawa.
Mazurek
A P
AP
D015195:Drug Design; D004353:Drug Evaluation, Preclinical / Q000379:methods; D015507:Drugs, Investigational / Q000737:chemistry*; D009904:Optical Rotation; D013237:Stereoisomerism
D015507:Drugs, Investigational
Zasady postepowania z lekami--zwiazkami optycznie czynnymi.